Moreover, upregulation of fascin has been considered as an "intermediate" event in pancreatic carcinoma progression, uncommon in early intraepithelial neoplasia lesions, but substantially upregulated in advanced intraepithelial neoplasia lesions and nearly universal in invasive cancers [24]. The gene discussed is FSCN1; the disease is exocrine pancreatic carcinoma.